Related Experiment Video
Updated: Jun 8, 2026

08:15
Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
Published on: February 3, 2022
Current concepts in drug-induced mitochondrial toxicity
Sashi Nadanaciva1, Yvonne Will
1Pfizer Inc., Groton, Connecticut, USA.
Current Protocols in Toxicology
|October 14, 2010
Summary
Mitochondria are vital for cellular functions, but drugs can cause mitochondrial dysfunction, leading to toxicity. Understanding these mechanisms is crucial for drug development and safety.
Area of Science:
- Cell Biology
- Biochemistry
- Toxicology
Background:
- Mitochondria are central to cellular energy production (ATP) and various metabolic processes.
- Drug-induced mitochondrial dysfunction is an emerging cause of drug toxicity.
- New research methods highlight the impact of drugs on mitochondrial health.
Purpose of the Study:
- To provide an overview of mitochondria's physiological roles.
- To elucidate the mechanisms through which drugs impair mitochondrial function.
- To highlight the significance of mitochondrial dysfunction in drug toxicity.
Main Methods:
- Literature review of mitochondrial physiology.
- Analysis of documented drug-induced mitochondrial impairments.
- Synthesis of information on drug toxicity mechanisms.
Main Results:
- Mitochondria perform critical functions including ATP generation, fatty acid oxidation, and apoptosis regulation.
- Drugs can disrupt mitochondrial function via multiple pathways, including oxidative phosphorylation inhibition and increased oxidative stress.
- Impairment of mtDNA replication or protein synthesis also contributes to toxicity.
Conclusions:
- Mitochondrial dysfunction is a significant factor in adverse drug reactions.
- A comprehensive understanding of drug-mitochondria interactions is essential for predicting and mitigating drug toxicity.
- Further research into these mechanisms can guide safer drug design.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

